139 related articles for article (PubMed ID: 35381761)
1. Tumor infiltrating lymphocytes in head and neck squamous cell carcinoma - Evaluation and clinical impact.
Dasgupta S; Chakrabarti S; Deb AR
J Cancer Res Ther; 2022; 18(1):49-54. PubMed ID: 35381761
[TBL] [Abstract][Full Text] [Related]
2. Is there any correlation between tumor infiltrating lymphocytes and expression of EGFR in squamous cell carcinoma of head and neck? A retrospective observational study.
Dasgupta S; Biswas N; Deb AR; Chakrabarti S
Indian J Pathol Microbiol; 2022; 65(2):262-267. PubMed ID: 35435357
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
Ahuja S; Khan AA; Zaheer S; Ranga S
Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
[TBL] [Abstract][Full Text] [Related]
4. Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy.
Choi S; Hossain M; Lee H; Baek J; Park HS; Lim CL; Han D; Park T; Kim JH; Gong G; Kweon MN; Lee HJ
Cancer Immunol Immunother; 2024 Apr; 73(6):101. PubMed ID: 38630265
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head-Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy.
Koukourakis IM; Gkegka AG; Xanthopoulou E; Nanos C; Giatromanolaki A; Koukourakis MI
Curr Oncol; 2022 Jun; 29(6):4274-4284. PubMed ID: 35735451
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
[TBL] [Abstract][Full Text] [Related]
7. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma.
Ngamphaiboon N; Chureemas T; Siripoon T; Arsa L; Trachu N; Jiarpinitnun C; Pattaranutaporn P; Sirachainan E; Larbcharoensub N
Med Oncol; 2019 Jan; 36(2):21. PubMed ID: 30666437
[TBL] [Abstract][Full Text] [Related]
9. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685
[TBL] [Abstract][Full Text] [Related]
10. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
[TBL] [Abstract][Full Text] [Related]
12. A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.
Shaban M; Khurram SA; Fraz MM; Alsubaie N; Masood I; Mushtaq S; Hassan M; Loya A; Rajpoot NM
Sci Rep; 2019 Sep; 9(1):13341. PubMed ID: 31527658
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Tumor Infiltrating Lymphocyte Density with Histopathological Parameters and Effect on Prognosis in Head and Neck Squamous Cell Cancers.
Sari E; Tokat T; Tarhan O; Dag H; Yilmaz YZ; Yener HM
Sisli Etfal Hastan Tip Bul; 2020; 54(4):438-443. PubMed ID: 33364884
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment nutritional status, HPV infection, and tumor infiltrating lymphocyte as prognostic predictors in patients with head and neck squamous cell carcinoma after chemotherapy.
Sutandyo N; Brahma B; Ifandriani R
J Cancer Res Ther; 2022 Dec; 18(Supplement):S177-S181. PubMed ID: 36510961
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of CD45 transcriptional expression in head and neck cancer.
Camacho M; Agüero A; Sumarroca A; López L; Pavón MÁ; Avilés-Jurado FX; García J; Quer M; León X
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):225-232. PubMed ID: 29177949
[TBL] [Abstract][Full Text] [Related]
16. Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.
De Keukeleire SJ; Vermassen T; De Meulenaere A; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Rottey S; Ferdinande L
Pathology; 2021 Dec; 53(7):836-843. PubMed ID: 34217516
[TBL] [Abstract][Full Text] [Related]
17. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
18. Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes.
Ge H; Ferris RL; Wang JH
Clin Cancer Res; 2023 Feb; 29(3):647-658. PubMed ID: 36315045
[TBL] [Abstract][Full Text] [Related]
19. Impact of HPV status on immune responses in head and neck squamous cell carcinoma.
Qureshi HA; Zhu X; Yang GH; Steadele M; Pierce RH; Futran ND; Lee SM; Méndez E; Houghton AM
Oral Oncol; 2022 Apr; 127():105774. PubMed ID: 35219073
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas.
Sánchez-Canteli M; Juesas L; Garmendia I; Otero-Rosales M; Calvo A; Alvarez-Fernández M; Astudillo A; Montuenga LM; García-Pedrero JM; Rodrigo JP
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
